Clinical Trials Browser

HER2-positive Breast Cancer × neratinib × Breast × Clear all

NCT07019272 2025-06-13

Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study

Not yet recruiting

HER2-positive Breast Cancer

NCT06693024 2024-11-20

NeraHER2

HER2-positive Breast Cancer

NCT05154396 2021-12-13

Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer

Phase 2 Unknown

HER2-positive Breast Cancer